Loading...
Log in
Free sign up
Home
Earnings
IPOs
Splits
Institutional
Insider
Reddit
SPACs
Sectors
Screeners
Crypto
HC Wainwright & Co. Maintains Buy on ChromaDex, Lowers Price Target to $7
CDXC
Dashboard
Financials
Data
Institutional
Insider
News
Filings
Transcripts
Reddit
ESG
Shorts
ETFs
Article
< Back
Share this news
Latest CDXC news
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
24 Jun 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
23 Jun 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
ChromaDex Signs Distribution Agreement With Sinopharm Xingsha Accelerate Cross-Border Sales Of Tru Niagen Into Mainland China
10 Jun 22
News
4 Analysts Have This to Say About ChromaDex
7 Jun 22
Analyst Ratings
HC Wainwright & Co. Maintains Buy on ChromaDex, Lowers Price Target to $7
7 Jun 22
News, Price Target, Analyst Ratings
Tue. 7 Jun 2022, 6:23am ET
Benzinga
News, Price Target, Analyst Ratings
CDXC
HC Wainwright & Co. analyst Raghuram Selvaraju maintains ChromaDex (NASDAQ:
CDXC
) with a Buy and lowers the price target from $8 to $7.
